Skip to content
New platform coming soon — AI-Based Analysis with Human-Generated Insights
Stock Target Advisor Stock Target Advisor Market intelligence
  • Research ▾
    • Equity Reports
    • STA Portfolio
    • Top Stocks
  • Market Analysis
  • Analyst Ratings
  • Stock Research Tools ▾
    • Analyst Target Tool
    • Analyst Ranking Tool
    • Stock Analysis Tool
  • About ▾
    • About STA
    • Services
    • Contribute
    • Contact
  • Social Media ▾
    • YouTube
    • Blossom
    • Substack
    • TikTok

Browse research

Tag: analyst ratings

Analog Devices (ADI) Analysts Update Coverage
Market News & Insights Feb 22, 2024

Stock Market Update for February 22rd, 2024

Global Markets (Sign Up Here: for access to all Analyst Ratings and  Stock Research) The tech-heavy Nasdaq, experienced a significant jump following…

#analyst ratings #Artificial Intelligence #Earnings
Can Rivian Compete in EV Market? Q4 Results Raise Concerns
Market News & Insights Feb 22, 2024

Can Rivian Compete in EV Market? Q4 Results Raise Concerns

Rivian Automotive (RIVN: NSD) saw its stock plummet over 15% in after-hours trading on Wednesday following its release of Q4 2023 earnings.…

#analyst ratings #Automotive #Earnings
Walmart's Earnings Potentially Reflected in Near-Record Share Prices (Consensus "Strong Buy")
Market News & Insights Feb 22, 2024

Walmart (WMT:NYE) Analyst Raise target Valuations

Analyst Ratings Update:  (Sign Up Here: for access to all Analyst Ratings and Ratings to your inbox) Recent analyst updates from  financial…

#analyst ratings #Retail Stocks #WMT:NYE
Snowflake (SNOW:NSD) Needham Upgrades target to $265
Market News & Insights Feb 22, 2024

Snowflake (SNOW:NSD) Needham Upgrades target to $265

Snowflake’s Analyst Rating Gets a Boost: (Sign Up Here: for access to all Analyst Ratings and Ratings to your inbox) Snowflake Inc.,…

#analyst ratings #SNOW:NSD #technology stocks
Analysts Downgrade Rapt Therapeutics on Trial Halts
Market News & Insights Feb 22, 2024

Analysts Downgrade Rapt Therapeutics on Trial Halts

Analyst Ratings for Rapt Therapeutics: (Sign Up Here: for access to all Analyst Ratings and Ratings to your inbox) Rapt Therapeutics, a…

#analyst ratings #energy stocks #Healthcare Stocks

Posts pagination

Previous 1 … 446 447 448 449 450 … 612 Next
Stock Target Advisor

Timely market news, analyst rating changes, and practical investment research for investors around the world.

  • Research
  • Analyst Ratings
  • Market Analysis
  • Top Stocks
  • About Us
  • Contact Us
  • Contribute a Post
© 2026 Stock Target Advisor. All rights reserved.

STA RESEARCH

Get the STA Research Professional Newsletter

Market outlook, portfolio updates, technical analysis and stock ideas—US$5/month.

See What’s Included →

Monthly subscription. Secure checkout with PayPal.